GOT1 and non-small cell lung carcinoma: Notably, previous data suggests that cisplatin regulated mitochondrial GOT1 to induce nephrotoxicity in rats [33], which rendered the possibility that targeting GOT1 might help to increase the therapeutic efficacy of cisplatin in NSCLC.